Document Detail


Case report: acute liver failure due to acute fatty liver of pregnancy.
MedLine Citation:
PMID:  21685863     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Acute fatty liver of pregnancy (AFLP) is a rare but serious liver disease and typically occurs during the third trimester. It carries the risk for significant perinatal and maternal mortality. Therefore an early diagnosis and delivery, followed by close monitoring and optimized management of the impaired liver function with all associated problems are necessary to prevent maternal and foetal death. This case report focuses on the management of acute liver failure due to AFLP in a 31 year old women treated in our intensive care unit (ICU) after an emergency C-section.
Authors:
S Wand; R Waeschle; N Von Ahsen; T Hawighorst; A Bräuer; M Quintel
Related Documents :
156733 - Deficient 3 beta-hydroxy-5-ene steroid secretion by newborn infants.
178853 - Hcg + acth stimulation of in vitro dehydroepiandrosterone production in human fetal adr...
17017653 - A field investigation of the use of the pedometer for the early detection of lameness i...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-6-17
Journal Detail:
Title:  Minerva anestesiologica     Volume:  -     ISSN:  1827-1596     ISO Abbreviation:  -     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-6-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375272     Medline TA:  Minerva Anestesiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Anesthesiology, Emergency and Intensive Care Medicine, University Hospital Goettingen, Goettingen, Germany - saskia.wand@med.uni-goettingen.de.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Promazine in the treatment of delusional parasitosis.
Next Document:  Alemtuzumab: what is the secret to safe therapy?